These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7520784)

  • 1. Increased fetal hemoglobin production in patients receiving valproic acid for epilepsy.
    Collins AF; Dover GJ; Luban NL
    Blood; 1994 Sep; 84(5):1690-1. PubMed ID: 7520784
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia.
    Fibach E; Prasanna P; Rodgers GP; Samid D
    Blood; 1993 Oct; 82(7):2203-9. PubMed ID: 7691251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of fetal hemoglobin synthesis indicating differentiation induction in children receiving valproic acid.
    Kieslich M; Schwabe D; Cinatl J; Driever PH
    Pediatr Hematol Oncol; 2003; 20(1):15-22. PubMed ID: 12687749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of fetal hemoglobin production by short chain fatty acids.
    Liakopoulou E; Blau CA; Li Q; Josephson B; Wolf JA; Fournarakis B; Raisys V; Dover G; Papayannopoulou T; Stamatoyannopoulos G
    Blood; 1995 Oct; 86(8):3227-35. PubMed ID: 7579419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders.
    Perrine SP; Olivieri NF; Faller DV; Vichinsky EP; Dover GJ; Ginder GD
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):67-71. PubMed ID: 7508690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation ofserum free carnitine/acylcarnitine levels and left ventricular systolic functions in children with idiopathic epilepsy receiving valproic acid.
    Kulhas Celik I; Tasdemir HA; Ince H; Celik H; Sungur M
    Clin Neurol Neurosurg; 2018 Jul; 170():106-112. PubMed ID: 29772401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies.
    Perrine SP; Faller DV
    Experientia; 1993 Feb; 49(2):133-7. PubMed ID: 7680003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperaminoacidemia in epileptic children treated with valproic acid.
    Castro-Gago M; Rodrigo-Saez E; Novo-Rodriguez I; Camiña MF; Rodriguez-Segade S
    Childs Nerv Syst; 1990 Dec; 6(8):434-6. PubMed ID: 2095300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin.
    Witt O; Monkemeyer S; Rönndahl G; Erdlenbruch B; Reinhardt D; Kanbach K; Pekrun A
    Blood; 2003 Mar; 101(5):2001-7. PubMed ID: 12393499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel valproic acid derivatives with hemoglobin F inducing activity.
    Rönndahl G; Mönkemeyer S; Schulze S; Pekrun A; Eikel D; Nau H; Witt O
    Am J Hematol; 2006 May; 81(5):374-6. PubMed ID: 16628726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of epilepsy and valproic acid on oxidant status in children with idiopathic epilepsy.
    Yiş U; Seçkin E; Kurul SH; Kuralay F; Dirik E
    Epilepsy Res; 2009 Apr; 84(2-3):232-7. PubMed ID: 19261443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid and augmentation of fetal hemoglobin in individuals with and without sickle cell disease.
    Selby R; Nisbet-Brown E; Basran RK; Chang L; Olivieri NF
    Blood; 1997 Jul; 90(2):891-3. PubMed ID: 9226193
    [No Abstract]   [Full Text] [Related]  

  • 13. The platelet aggregation in children with epilepsy receiving valproic acid.
    Tanindi S; Akin R; Koseoglu V; Kurekci AE; Gokcay E; Ozcan O
    Thromb Res; 1996 Feb; 81(4):471-6. PubMed ID: 8907296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five doubly unsaturated metabolites of valproic acid in urine and plasma of patients on valproic acid therapy.
    Kochen W; Sprunck HP; Tauscher W; Klemens M
    J Clin Chem Clin Biochem; 1984 Apr; 22(4):309-17. PubMed ID: 6429268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of valproic acid in children with severe epilepsy: clearance and hepatotoxicity.
    Dodson WE; Tasch V
    Neurology; 1981 Aug; 31(8):1047-50. PubMed ID: 6791048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid: a new antiepileptic agent.
    Brown LW
    Am Fam Physician; 1979 Feb; 19(2):166-8. PubMed ID: 367133
    [No Abstract]   [Full Text] [Related]  

  • 17. Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid.
    Serdaroglu G; Tütüncüoglu S; Kavakli K; Tekgül H
    J Child Neurol; 2002 Jan; 17(1):41-3. PubMed ID: 11913569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid: a brief review.
    Cruse RP; Rothner AD; Erenberg G; Henry C; Jugenheimer K
    Ohio State Med J; 1978 Oct; 74(10):629-31. PubMed ID: 362269
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma GABA levels in neurological patients under treatment with valproic acid.
    Löscher W; Schmidt D
    Life Sci; 1981 May; 28(21):283-8. PubMed ID: 6789023
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of valproic acid on plasma carnitine levels.
    Opala G; Winter S; Vance C; Vance H; Hutchison HT; Linn LS
    Am J Dis Child; 1991 Sep; 145(9):999-1001. PubMed ID: 1877582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.